ロード中...

Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank

INTRODUCTION: Intravenous augmentation therapy with purified intravenous alpha-1 antitrypsin replaces the deficient protein and is the only currently approved treatment for alpha-1 antitrypsin deficiency (AATD) related lung disease. While augmentation therapy has been available for more than 20 year...

詳細記述

保存先:
書誌詳細
主要な著者: Tonelli, Adriano R, Rouhani, Farshid, Li, Ning, Schreck, Pam, Brantly, Mark L
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2009
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2802045/
https://ncbi.nlm.nih.gov/pubmed/20054436
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!